What is the Catalyst Edge convergence score for ELOXD?

As of 2026-09-10, ELOXD has a convergence score of — with conviction tier — and 0 independent signals firing. Score is a weighted aggregate across SEC filings, insider activity, options flow, dark-pool prints, short-squeeze metrics, and macro regime.

How is ELOXD's score calculated?

Each signal contributes weighted points; weights are auto-tuned weekly against published outcome history. Full methodology + audit at https://catalystedgescanner.com/methodology/ and https://catalystedgescanner.com/trust/.

ELOXD — Catalyst score — (—) · Unclassified

$ELOXD

Unclassified · convergence — · conviction —

Convergence Score

—

Conviction

—

Signals Firing

Price & Live Quote

Loading live quote & chart…

Practice trade tools

Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.

Paper trade unavailable: missing risk-bounded frame

Reference only. Not financial advice. No brokerage order is placed.

Why $ELOXD?

ELOXD 3 ELEVATED

Quantitative

Short scanner score: 3 (1 signals · 1 bearish forms YoY)

Catalysts

Dilution / supply forms: Recent SEC filings: 424B4 — bearish supply signal
Short scanner signals: 424B4 (+3)
Recency: Last bearish filing 2704 minutes ago
SEC filing link: https://www.sec.gov/Archives/edgar/data/1035354/000119312526263914/0001193125-26-263914-index.htm

Risks

Squeeze risk: Short positions exposed to overnight gap-up squeezes
Hard-to-borrow tail: Bearish setups on RegSHO threshold names face borrow-rate spikes and recall risk

Bear case

Bullish surprise (short-thesis failure): Issuer announcement could reverse the supply narrative overnight
Sector rotation tailwind: Sector group bid in a risk-on day means even weak names rally — short timing matters

Sympathy basket (cerebro)

BIIB via biotech r=+0.00 score-cohort (score 28)
PFE via pharma r=+0.00 score-cohort (score 24)
ABBV via pharma r=+0.00 score-cohort (score 23)
D via utilities r=+0.00 score-cohort (score 22)
QQQ via tech_mega r=+0.00 score-cohort (score 22)
BMY via pharma r=+0.00 score-cohort (score 21)

Signals Firing

No active signals this cycle.

Each tag is a spoke that flagged this ticker today. Weights tuned weekly against published outcomes.

Earnings Catalyst

No recent earnings event.

Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks and its losses — see the trust report and methodology. Not financial advice. Confirm independently before trading.

$99 once — every ticker on this site ranked before the open.

Tier 1 setups touched +2% intraday 48.9% of the time across 374 tracked calls. Baseline for everything else: 41.0%. That is a +7.9 point edge, measured from the NEXT OPEN — the first price you could actually pay, not the prior close. We publish the misses too: https://catalystedgescanner.com/trust/

Click Become a Founding Member below.

Pay $99 once — not monthly, not ever again.

You keep every future release at that price. Tomorrow's ranked list lands at 3:30 AM ET, before the open.

29 of 30 founding seats left. The price goes up when they are gone.

Become a Founding Member — $99 once

One payment. Lifetime access. The free daily picks stay free — this is for people who want the full console. Not buying today? Get tomorrow's ranked list free →